Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Huaier Granule on Postoperative Adjuvant Treatment for High-risk Early-stage Triple-negative Invasive Ductal Carcinoma: a Prospective, Multicenter, Randomized, Controlled, Open-label Study

NCT04790305 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04790305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04790305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Huaier Granule on Postoperative Adjuvant Treatment for High-risk Early-stage Triple-negative Invasive Ductal Carcinoma: a Prospective, Multicenter, Randomized, Controlled, Open-label Study
Lead sponsor
Fudan University
Phase
Phase 4
Overall status
Recruiting
Start date
June 18, 2021
Completion date
July 28, 2028
Enrollment
1,072 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma breast, invasive ductal carcinoma, breast, triple-negative breast cancer